Parstatin (mouse) (TFA)

OC(C(F)(F)F)=O.O=C([C@@H](N)CCSC)NCC(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N2[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N3[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N4[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N5[C@H](C(N[C@H](C(O)=O)CCCNC(N)=N)=O)CCC5)=O)CC(N)=O)=O)C(C)C)=O)[C@@H](C)O)=O)C)=O)CC(O)=O)=O)[C@@H](C)O)=O)CCCNC(N)=N)=O)CCC(O)=O)=O)CO)=O)CCC(O)=O)=O)CCC4)=O)CCC(N)=O)=O)CO)=O)CCSC)=O)CCC3)=O)C(C)C)=O)CCCNC(N)=N)=O)CO)=O)CO)=O)CC(C)C)=O)CC(C)C)=O)CCC2)=O)=O)CS)=O)CC(C)C)=O)CO)=O)CC(C)C)=O)=O)CC(C)C)=O)C)=O)C(C)C)=O)[C@H](CC)C)=O)CC(C)C)=O)CC(C)C)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC1)=O

[1]Panagiota Zania, et al. Parstatin, the Cleaved Peptide on Proteinase-Activated Receptor 1 Activation, Is a Potent Inhibitor of Angiogenesis. J Pharmacol Exp Ther. 2009 Feb;328 (2) :378-89.|[2]Jennifer L Strande, et al. Parstatin: A Cryptic Peptide Involved in Cardioprotection After Ischaemia and Reperfusion Injury. Cardiovasc Res. 2009 Jul 15;83 (2) :325-34.